Home › Chronic Kidney Disease
Chronic Kidney Disease clinical trials recruiting in the U.S.
114 studies for Chronic Kidney Disease are recruiting participants at sites across the United States.
If your kidneys are damaged and can't filter blood easily, then you may suffer from chronic kidney disease (CKD). Read about the treatments available
Cities with the most studies
- New York City, NY16 studies
- Philadelphia, PA15 studies
- Boston, MA15 studies
- Houston, TX14 studies
- Dallas, TX14 studies
- Chicago, IL12 studies
- Orlando, FL11 studies
- Atlanta, GA9 studies
- Kansas City, MO8 studies
- San Antonio, TX8 studies
- Durham, NC8 studies
- Los Angeles, CA7 studies
- Albuquerque, NM7 studies
- Miami, FL7 studies
- Washington, DC7 studies
- Pittsburgh, PA6 studies
- Ann Arbor, MI6 studies
- St. Louis, MO6 studies
- Cincinnati, OH6 studies
- Aurora, CO6 studies
- Jacksonville, FL5 studies
- Memphis, TN5 studies
- New Haven, CT5 studies
- Hollywood, FL5 studies
- Santa Monica, CA5 studies
- The Bronx, NY5 studies
- Queens, NY5 studies
- Mountain View, CA5 studies
- Nashville, TN5 studies
- Birmingham, AL5 studies
- Salt Lake City, UT5 studies
- Minneapolis, MN4 studies
- Baltimore, MD4 studies
- Rochester, MN4 studies
- Little Rock, AR4 studies
- Arlington, TX4 studies
- Huntsville, AL4 studies
- Santa Clarita, CA4 studies
- McKinney, TX4 studies
- Pomona, CA4 studies
By state
- Alabama11 studies
- Arizona8 studies
- Arkansas4 studies
- California23 studies
- Colorado12 studies
- Connecticut8 studies
- District of Columbia4 studies
- Florida23 studies
- Georgia14 studies
- Illinois17 studies
- Indiana6 studies
- Iowa4 studies
- Kentucky3 studies
- Louisiana3 studies
- Maryland9 studies
- Massachusetts17 studies
- Michigan12 studies
- Minnesota11 studies
- Mississippi5 studies
- Missouri15 studies
- Nebraska3 studies
- Nevada4 studies
- New Jersey6 studies
- New Mexico8 studies
- New York27 studies
- North Carolina17 studies
- Ohio14 studies
- Oregon5 studies
- Pennsylvania20 studies
- South Carolina7 studies
- Tennessee12 studies
- Texas24 studies
- Utah6 studies
- Virginia7 studies
- Washington4 studies
Recently updated studies
Immune System Related Kidney Disease
RecruitingObservational study
Ages 10 to 99 · All sexes · Updated Nov 12, 2026 · NCT00001979A Study to Investigate Safety, Tolerability, PK, and PD of AZD4248 in Healthy Participants, Participants With CKD and Type 2 Diabetes, Assess Home Measurements of Creatinine in a Non-Interventional Cohort, and Assess the Effect of AZD4248 on the PK of Midazolam and Metformin in Healthy Participants
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Nov 12, 2026 · NCT07024823Ticagrelor for Inflammation and Cardiovascular Risk in Patients With Chronic Kidney Disease
RecruitingPhase 2Healthy volunteers welcome
Ages 21 to 75 · All sexes · Updated Nov 10, 2026 · NCT07911124University of Michigan "Nephrology Research BioBank"
RecruitingObservational study
All ages · All sexes · Updated Nov 10, 2026 · NCT00381121Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Nov 10, 2026 · NCT07235059Effects of Replacing High Protein Foods in People With Chronic Kidney Disease
Recruiting
Ages 40 to 70 · All sexes · Updated Nov 9, 2026 · NCT07105670A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07268638A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT06742723Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
RecruitingPhase 3
Ages 2 to 18 · All sexes · Updated Nov 6, 2026 · NCT07498335Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population
Recruiting
Ages 18 to 80 · All sexes · Updated Nov 5, 2026 · NCT05981183Clinical Decision Support for SGLT2i After AKI in Type 2 Diabetes
Recruiting
Ages 30 to 75 · All sexes · Updated Nov 4, 2026 · NCT07868666A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07783802Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
RecruitingPhase 2
Ages 40 to 75 · All sexes · Updated Oct 30, 2026 · NCT05928936Diuretic Tuner Clinical Decision Support
Recruiting
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT04759274Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD)
Recruiting
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT06927024Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Oct 27, 2026 · NCT07271186A Natural History Study of Metabolic Sizing in Health and Disease
RecruitingObservational studyHealthy volunteers welcome
Ages 2 to 99 · All sexes · Updated Oct 27, 2026 · NCT05398783Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias
RecruitingObservational study
Ages 19 and older · All sexes · Updated Oct 26, 2026 · NCT06306963The KidneyCARE (Community Access to Research Equity) Study
RecruitingObservational study
Ages 18 to 120 · All sexes · Updated Oct 26, 2026 · NCT05497518SPYRAL GEMINI Pilot Study
Recruiting
Ages 18 to 80 · All sexes · Updated Oct 20, 2026 · NCT06907147Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation
RecruitingEarly phase 1
Ages 18 to 70 · All sexes · Updated Oct 14, 2026 · NCT07358195American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
RecruitingObservational study
Ages 21 to 80 · All sexes · Updated Oct 13, 2026 · NCT04185844A Study of Luspatercept in People With Anemia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 13, 2026 · NCT07725497CKD Awareness, Referrals, Education, and Support Intervention for Early-Stage CKD
Recruiting
Ages 18 and older · All sexes · Updated Oct 9, 2026 · NCT07210710Physical Activity in CKD
Recruiting
Ages 13 to 18 · All sexes · Updated Oct 8, 2026 · NCT06624358From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.